Aclaris Therapeutics, Inc.
ACRS· Nasdaq
ACRSAclaris Therapeutics, Inc.
Quarterly figures for Aclaris Therapeutics, Inc., with source filings when available.
50 quarters. Mar 31, 2014 to Jun 30, 2026. USD.
Aclaris Therapeutics, Inc. has filed its 10-Q within 37 to 38 days of period end across its last 8 quarters. The 10-K runs 54 to 77 days.
Aclaris Therapeutics, Inc. · CIK 1557746 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · pre-market | Aug 6, 2026 | 37 d | 10-Q | $1.63M | −8.3% | -$0.15 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 7, 2026 · pre-market |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $2.00M |
| +37.2% |
| -$0.15 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 26, 2026 · pre-market | Feb 26, 2026 | 57 d | 10-K | $1.30M | −85.9% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · pre-market | Nov 6, 2025 | 37 d | 10-Q | $3.30M | −24.1% | -$0.12 | |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 · pre-market | Aug 7, 2025 | 38 d | 10-Q | $1.78M | −35.8% | -$0.13 | |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 · pre-market | May 8, 2025 | 38 d | 10-Q | $1.46M | −39.3% | -$0.12 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 27, 2025 · pre-market | Feb 27, 2025 | 58 d | 10-K | $9.21M | −47.6% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 6, 2024 · pre-market | Nov 6, 2024 | 37 d | 10-Q | $4.35M | −53.2% | -$0.11 | |
| Q2 2024 | Jun 30, 2024 | Aug 7, 2024 · pre-market | Aug 7, 2024 | 38 d | 10-Q | $2.77M | +48.0% | -$0.15 | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · after-hours | May 7, 2024 | 37 d | 10-Q | $2.40M | −5.1% | -$0.24 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 27, 2024 · pre-market | Feb 27, 2024 | 58 d | 10-K | $17.57M | +126.6% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · pre-market | Nov 6, 2023 | 37 d | 10-Q | $9.28M | −51.2% | -$0.41 | |
| Q2 2023 | Jun 30, 2023 | Aug 7, 2023 · pre-market | Aug 7, 2023 | 38 d | 10-Q | $1.87M | +22.3% | -$0.42 | |
| Q1 2023 | Mar 31, 2023 | May 8, 2023 · pre-market | May 8, 2023 | 38 d | 10-Q | $2.53M | +74.0% | -$0.42 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 23, 2023 · pre-market | Feb 23, 2023 | 54 d | 10-K | $7.75M | +416.5% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · pre-market | Nov 8, 2022 | 39 d | 10-Q | $19.02M | +1,046.4% | -$0.30 | |
| Q2 2022 | Jun 30, 2022 | Aug 3, 2022 · pre-market | Aug 3, 2022 | 34 d | 10-Q | $1.53M | −16.2% | -$0.31 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · pre-market | May 10, 2022 | 40 d | 10-Q | $1.45M | −18.2% | -$0.31 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 24, 2022 · pre-market | Feb 24, 2022 | 55 d | 10-K | $1.50M | −5.0% | — | |
| Q3 2021 | Sep 30, 2021 | Nov 2, 2021 · pre-market | Nov 2, 2021 | 33 d | 10-Q | $1.66M | +14.5% | -$0.35 | |
| Q2 2021 | Jun 30, 2021 | Aug 5, 2021 · pre-market | Aug 5, 2021 | 36 d | 10-Q | $1.82M | −10.9% | -$0.34 | |
| Q1 2021 | Mar 31, 2021 | May 7, 2021 · pre-market | May 7, 2021 | 37 d | 10-Q | $1.78M | +26.3% | -$0.57 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Feb 25, 2021 · pre-market | Feb 25, 2021 | 56 d | 10-K | $1.58M | +44.3% | — | |
| Q3 2020 | Sep 30, 2020 | Nov 4, 2020 · pre-market | Nov 4, 2020 | 35 d | 10-Q | $1.45M | +47.4% | -$0.25 | |
| Q2 2020 | Jun 30, 2020 | Aug 7, 2020 · pre-market | Aug 7, 2020 | 38 d | 10-Q | $2.05M | +130.9% | -$0.28 | |
| Q1 2020 | Mar 31, 2020 | May 7, 2020 · after-hours | May 7, 2020 | 37 d | 10-Q | $1.41M | +11.4% | -$0.37 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | Feb 25, 2020 · after-hours | Feb 25, 2020 | 56 d | 10-K | $1.10M | −70.2% | — | |
| Q3 2019 | Sep 30, 2019 | Nov 7, 2019 · after-hours | Nov 7, 2019 | 38 d | 10-Q | $983.00K | −12.1% | -$1.34 | |
| Q2 2019 | Jun 30, 2019 | Aug 8, 2019 · after-hours | Aug 8, 2019 | 39 d | 10-Q | $886.00K | −75.9% | -$1.21 | |
| Q1 2019 | Mar 31, 2019 | May 8, 2019 · after-hours | May 8, 2019 | 38 d | 10-Q | $1.26M | +13.0% | -$0.91 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | Mar 18, 2019 · pre-market | Mar 18, 2019 | 77 d | 10-K | $3.67M | +267.3% | -$0.99 | |
| Q3 2018 | Sep 30, 2018 | Nov 6, 2018 · after-hours | Nov 6, 2018 | 37 d | 10-Q | $1.12M | +63.5% | -$1.06 | |
| Q2 2018 | Jun 30, 2018 | Aug 3, 2018 · pre-market | Aug 3, 2018 | 34 d | 10-Q | $3.68M | — | -$1.01 | |
| Q1 2018 | Mar 31, 2018 | May 8, 2018 · after-hours | May 8, 2018 | 38 d | 10-Q | $1.12M | — | -$0.98 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | Mar 12, 2018 · pre-market | Mar 12, 2018 | 71 d | 10-K | $999.00K | — | -$0.74 | |
| Q3 2017 | Sep 30, 2017 | Nov 7, 2017 · pre-market | Nov 7, 2017 | 38 d | 10-Q | $684.00K | — | -$0.63 | |
| Q2 2017 | Jun 30, 2017 | Aug 8, 2017 · pre-market | Aug 8, 2017 | 39 d | 10-Q | — | — | -$0.56 | |
| Q1 2017 | Mar 31, 2017 | May 9, 2017 · after-hours | May 9, 2017 | 39 d | 10-Q | — | — | -$0.48 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 15, 2017 | 74 d | 10-K | — | — | -$0.49 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 3, 2016 | 34 d | 10-Q | — | — | -$0.50 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 11, 2016 | 42 d | 10-Q | — | — | -$0.62 | |
| Q1 2016 | Mar 31, 2016 | — | May 11, 2016 | 41 d | 10-Q | — | — | -$0.65 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Mar 23, 2016 | 83 d | 10-K | — | — | -$0.28 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 18, 2015 | 49 d | 10-Q | $0.00 | — | -$5.12 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | — | — | -$1.52 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | — | — | -$1.61 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | — | — | — | — | — | -$1.76 | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $0.00 | — | -$1.75 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | — | — | -$1.61 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | — | — | -$0.95 | |
